Proteomics is a part of molecular biology that studies proteins. A proteome is a set of proteins that are either produced or modified by an organism and proteomics helps us understand things like the structure and function of the protein in an organism. The first studies of proteins that could be called proteomics were done in 1975 with the bacterium Escherichia coli. Today, the study of proteomics includes protein-protein interaction, function, modifications, and localization studies.
Profile Techniques
- Structural proteomics compares protein structures and helps with identifying genes that are newly discovered. It also identifies where drugs bind to the proteins and where proteins interact with each other. X-ray crystallography and nuclear magnetic resonance spectroscopy are two technologies that aid in structural proteomics.
- Expression proteomics is the study of protein expression which is used to identify the main proteins found in a sample and related samples, often used to compare healthy tissue with diseased tissue. Technologies that help with expression proteomics include 2D-PAGE and mass spectroscopy.
- Functional proteomics refers to protein-protein interactions to determine the functions of different proteins, as well as to demonstrate how proteins assemble.
If you are a laboratory that performs proteomic testing or research, you can view all of our proteomic test requests here. These requests include:
- Africa Agriculture Bioanalytical Laboratory is needed for Proteomics analysis on tomato leaf and fruit subjected to two water treatments.
- Ph.D. scholar working in rice proteomics needs a China informatics laboratory with proteomics bioinformatics tools to analyze proteomics research data.
- West Coast USA Bioanalytical Proteomics Laboratory needed for Protein isolation and enzyme testing
- Proteomics Biotechnology Company needs a preclinical, oncology Contract Research Organization for Biomarker, Microarray Discovery, and development study (proteomics-based). We are actually working on a compound able to inhibit a signaling pathway involved in cancer progression. Several pre-clinical trials suggest a possible role of our compound in breast and prostate cancer. The key remaining issue today is to identify a valid PD Marker prior to the first administration to man.
- and more!
If you are an organization in need of proteomics testing, research, or analysis, you can call us at 1-855-377-6821 or submit your proteomics test request online here.
